The US health regulator, the Food and Drug Administration (FDA) yesterday approved a new drug named Hemgenix to treat hemophilia B, and now it has become the most expensive drug in the world
The breakthrough medicine, which is available at a price of $3.5 million per treatment, was developed by the US-based biopharmaceutical company CSL Behring
Not just Hemgenix, there are many other costly drugs available in the market that seem to be almost unattainable. Here, let’s know about a few other expensive drugs after Hemgenix
Zolgensma
Developed by Novartis, the price of the Zolgensma drug is
$2,125,000
(one-time cost). Approved by FDA in 2019, Zolgensma is the second most costly drug available in the market
Zokinvy
Developed by Eiger BioPharmaceuticals, the cost of the Zokinvy, is
$1,073,760
(for a year’s supply)
Danyelza
Danyelza is used to treat neuroblastoma in the bone or bone marrow of paediatric and adult patients.
It costs around
$1,011,882
( for a year's supply)
Kimmtrak
Manufactured by Immunocore Ltd, Kimmtrack is used to treat patients with metastatic or surgically untreatable uveal melanoma (cancer). The drug approved by FDA in 2022 will cost
$975,520
per year
Myalept
At
$929,951
a year, Myalept is used to treat patients with congenital generalised lipodystrophy